Search IconSearch Cart IconCart User IconMy Vazyme
Top IconTOP
About Us Our Stories

Our History

Our Stories
2012
Found
Vazyme was established including a number of biomolecular research reagent product lines with independent intellectual property rights.
2015
Go Global
The International Business Department was set up with the belief of becoming the professional supplier of In Vitro Diagnostic Solutions worldwide.
2016
IVD Business
Vazyme Medical Technology CO., Ltd was established, which aimed to deploy IVD testing reagents and instruments.
2019
Biomedical Business
Several key projects of Vazyme Medical passed the External Quality Assessment (EQA) of the National Center for Clinical Laboratories with full marks.
2020
Response to COVID-19
COVID-19 Solutions with high detection sensitivity were developed by Vazyme professional team and certified by countries and regions worldwide from all over the world.
2021
Listed on SSE
Vazyme went public on the STAR Market of the Shanghai Stock Exchange under the stock code 688105.
2022
10 Years for Science
Since 2012, Vazyme has been committed to innovation and creating value for our customers. In 2021, Vazyme was ranked among the top 500 listed companies in China and achieved ISO 13485 certification.
2023
Innovation in Motion
Vazyme upgraded its production lines in cell and protein research reagents and instruments to provide customers with full-stack solution in life science.
2024
Breakthroughs in New Areas
Vazyme launched a highly sensitive blood test solution for the early diagnosis of Alzheimer's Disease with industrial partners, accelerating the progress of AD diagnosis and treatment.
FUTURE
Our Stories Our Stories

The Story of Vazyme:

Developing Enzyme-based Solution

to Boost Science Exploration

In 2012, Dr. Cao Lin set out on a remarkable journey. As a university professor, he often faced the frustration of expensive reagents and long waiting times—barriers that slowed scientific progress. Fueled by a passion to make research easier and more accessible, Dr. Cao gathered a group of like-minded friends. Together, they founded Vazyme. The team devoted itself to research, nurtured young talents, and embraced new technologies. Step by step, Vazyme grew, attracting outstanding minds and earning the trust of partners worldwide.
Our Leadership
Dr. Cao Lin
“We leverage our professional expertise, uphold the highest standards, and are rigorously engaged in research and development. ”
Dr. Cao Lin
Founder, Chairman and General Manager

PhD in Biochemistry, Nanjing University

China Europe International Business School Senior EMBA

Entrepreneurship Talent of Jiangsu Province

We leverage our professional expertise, uphold the highest standards, and are rigorously engaged in research and development. Our commitment to addressing the diverse needs of our customers propels us to constantly explore new frontiers in bioactive compounds, ensuring that we provide comprehensive and innovative solutions.
Mr. Xu Xiaoyu
Mr. Xu Xiaoyu
Senior Vice President

Head of Bio-medicine Division

Master of Biochemistry, Nanjing University

13+ years of experience in protein engineering

Dr. Zhang Lijun
Dr. Zhang Lijun
Senior Vice President

Head of International Business Division

PhD in Biology, Nanjing University

13+ years of experience in molecular biology

Dr. Tang Bo
Dr. Tang Bo
Senior Vice President

Head of IVD Division

PhD in Biochemistry, Nanjing University

15+ years of experience in virology and immunology

Developed a platform for rabbit monoclonal antibodies

Ms. Hu Xiaomei
Ms. Hu Xiaomei
Senior Vice President

Head of Public Relationship Department

Master of Business Administration, City University of Macau

20+ years of enterprise management experience

Our Team Learn More